New NEC monitor receives FDA clearance

NEC Display Solutions of America announced today that its MultiSync MD211G5 medical-grade monitor has received FDA clearance for use in tomosynthesis and full field digital mammography (FFDM).

“We are honored to receive FDA clearance for use in tomosynthesis and FFDM in addition to the earlier FDA 510(k) clearance for mammography,” Art Marshall, a senior product manager with NEC, said in a press release. “This demonstrates NEC’s commitment to providing the right products for every modality our customers require.”

The 21-inch, five-megapixel grayscale monitor boasts out-of-the-box factory DICOM calibration designed to promote consistent imaging across the display, the company said.

Click here for the full press release.

John Hocter,

Digital Editor

With nearly a decade of experience in print and digital publishing, John serves as Content Marketing Manager. His professional skill set includes feature writing, content marketing and social media strategy. A graduate of The Ohio State University, John enjoys spending time with his wife and daughter, along with a number of surprisingly mischievous indoor cacti.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.